Stay informed about the latest health and medical news by subscribing to STAT’s free newsletter Morning Rounds. Sign up today for your daily dose of information.
Good day. Yesterday, writer and podcaster Aubrey Gordon shared a post that introduced me to a captivating photo series by artist Haley Morris-Cafiero called “Wait Watchers.” These photos capture the subtle judgment and scrutiny that Morris-Cafiero, a plus-sized woman, experiences in everyday public settings.
FDA Proposes Easier Access to Testosterone for Cis Men
Following the removal of stringent warning labels for menopausal hormone therapy, the FDA recently held a panel discussion on testosterone, another hormone treatment with associated warnings. Although the black box warning linking testosterone to cardiovascular risk was removed, concerns about prostate cancer risks remain. The panel, consisting of medical experts and industry representatives, supported the removal of the warning and advocated for rescheduling testosterone to a lower drug classification. Discover more insights from the discussion in STAT’s coverage by Annalisa Merelli.
Decline in Hospitals with Pediatric Capabilities
A recent study published in Pediatrics revealed a significant decrease in the number of hospitals equipped to provide pediatric care over the past two decades. The analysis of nearly 4,000 hospitals showed a decline in all levels of pediatric capabilities, with some institutions no longer offering comprehensive pediatric services beyond emergency care or obstetrics. Factors such as reduced Medicaid reimbursements and a shortage of pediatric providers were cited as contributing to this decline. Learn more about the implications of this trend.
Understanding Myocarditis
While Covid-19 vaccines have proven safe and effective, cases of myocarditis, or inflammation of the heart muscle, have been reported as rare side effects. A recent study published in Science Translational Medicine identified immune signals believed to trigger myocarditis in some vaccine recipients. The researchers also presented early findings suggesting that these signals could potentially be blocked. Explore the scientific insights into this rare but important issue.
Throughout the year, STAT reporters have been documenting the impact of policy changes on the science community. In the latest update, former FDA employee Karen Hollit and ex-NIH employee Josh Fessel share their experiences post-policy changes. Follow their journeys and learn how they have navigated the evolving landscape of science.
(Avoid) Discussing Cannabis Use During Pregnancy
Despite medical advice against using cannabis during pregnancy, a study published in JAMA Network Open revealed concerning attitudes among cannabis shop employees. While most budtenders advised against tobacco and blunt use during pregnancy, a significant portion considered cannabis use safe. Prenatal cannabis use has been linked to adverse outcomes for both mothers and babies, emphasizing the importance of accurate information dissemination. Discover the implications of these findings and the need for improved education in cannabis retail environments.
Timing of MPOX Vaccine Booster Trials
In a compelling First Opinion essay, scientists advocate for initiating booster trials for the MPOX vaccine amidst rising case numbers in major cities. With uncertainty surrounding the ideal timing for booster shots, the authors highlight the urgency of conducting research to provide guidance to the community. Explore the challenges and considerations involved in launching booster trials for the MPOX vaccine.
Recommended Reads
-
Harvard dismisses director of FXB Center for Health and Human Rights, The Harvard Crimson
-
This HIV expert refused to censor data, then quit the CDC, KFF Health News
- Top HHS official evades discussing Trump plan to block state AI laws, STAT
- ICE is using smartwatches to track pregnant women, even during labor, The Guardian
- Sperm donor with rare cancer-causing mutation fathers nearly 200 children across Europe, STAT
- House Democrat seeks to impeach Kennedy for undercutting public health, New York Times
